Prevention & care
How to read health evidence
On this page
A useful research answer states the question, methods, findings, and uncertainty. A paper’s abstract is a summary; detailed methods and results provide context needed to interpret its conclusion.[1]
Translate a health claim into an answerable question
Before comparing papers, record the population, treatment or exposure, comparator, outcome and follow-up. For interventions, dose, duration and co-interventions matter. Extract who was actually analyzed, funding and reported harms as well as benefits. Several papers may describe one study, so treating each publication as an independent experiment can overcount the evidence. A result measured after weeks cannot directly answer a question about years.[4]
A phase label is not a completeness or certainty grade
FDA describes a typical development sequence with changing safety and efficacy questions. Early phases can miss less common adverse effects; larger and later work may add information. This framework concerns medical-product development. It is not a rule that every nutrition, surgery or behavioral study follows the same sequence.[9]
A registered study is not automatically a positive result
ClinicalTrials.gov states that sponsors or investigators submit study information and are responsible for its accuracy, safety and science. The US government does not review or approve all listed studies. A registry identifier identifies a record; it does not independently establish successful treatment, completed follow-up or government endorsement.[10]
A trial’s plan, its status, posted results and a journal analysis answer different questions. Readers need the actual findings and methods rather than treating the existence of a study record as its conclusion. The platform’s disclaimer is not a verdict that every listed study is unreliable.[10]
Evidence & uncertainty
Certainty belongs to a defined question and outcome. A study-design label or publication count alone cannot supply a final verdict; this atlas has not independently applied GRADE.[2]
Selected-source overview · Independent review pendingPublished questions
Does a randomized-trial label automatically make a conclusion certain?
Selected-source overview · Independent review pending. Read the evidence context.
No. Bias, inconsistency, indirectness, imprecision, and publication bias still need assessment across the evidence.[2]
Evidence behind this answer
- Chapter 14: Summary of findings and certainty of evidence
methods handbook · 2024
Selected page text; cited sections · 14.1; 14.2.1–14.2.2
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Should one certainty rating be applied to every outcome of a treatment?
Selected-source overview · Independent review pending. Read the evidence context.
No. Cochrane’s GRADE approach assesses certainty for each individual outcome.[2]
Evidence behind this answer
- Chapter 14: Summary of findings and certainty of evidence
methods handbook · 2024
Selected page text; cited sections · 14.1; 14.2.1–14.2.2
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does randomized mean blinded?
Selected-source overview · Independent review pending. Read the evidence context.
No. Randomization concerns assignment; blinding concerns knowledge of treatment. Both need their own description and assessment.[5]
Evidence behind this answer
- Assessing risk of bias in a randomized trial
methods handbook · 2024
Selected handbook sections; not a full independent methods review · Sections 8.2–8.4: randomization, missing data and selective reporting
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Can I trust a review because it calls itself systematic?
Selected-source overview · Independent review pending. Read the evidence context.
Inspect its search, eligibility rules and selection process. A title or large bibliography does not establish comprehensive, reproducible methods.[3]
Evidence behind this answer
- Searching for and selecting studies
methods handbook · 2025
Selected handbook sections; not a full independent methods review · Sections 4.2–4.4: search coverage and multiple reports
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Is an abstract enough to judge all benefits and harms?
Selected-source overview · Independent review pending. Read the evidence context.
Usually not. Full reports contain study characteristics, outcomes and analysis details that a short abstract may omit.[4]
Evidence behind this answer
- Collecting data
methods handbook · 2024
Selected handbook sections; not a full independent methods review · Sections 5.2–5.4: study characteristics, outcomes and data sources
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does a meta-analysis automatically provide high-certainty evidence?
Selected-source overview · Independent review pending. Read the evidence context.
No. Combining studies does not eliminate their biases, differing populations or uncertainty about the question being asked.[6]
Evidence behind this answer
- Analysing data and undertaking meta-analyses
methods handbook · 2024
Selected handbook sections; not a full independent methods review · Sections 10.1–10.2: purpose and limits of pooling
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Has this atlas independently performed GRADE for every answer?
Selected-source overview · Independent review pending. Read the evidence context.
No. Formal certainty judgments require an outcome-specific body-of-evidence assessment with stated reasons; selected source reading is a different process.[2]
Evidence behind this answer
- Chapter 14: Summary of findings and certainty of evidence
methods handbook · 2024
Selected page text; cited sections · 14.1; 14.2.1–14.2.2
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
What should I check behind a podcast’s claim that a study proved something?
Selected-source overview · Independent review pending. Read the evidence context.
Check the design, who was studied, the intervention or exposure, comparison, outcome and follow-up. Look for reported harms, missing data, funding and analysis limitations, then compare the wider evidence. A short-term result cannot establish years of benefit, and multiple papers may describe one study. A confident headline is not an outcome-specific certainty assessment.[4][2][5]
Evidence behind this answer
- Collecting data
methods handbook · 2024
Selected handbook sections; not a full independent methods review · Sections 5.2–5.4: study characteristics, outcomes and data sources - Chapter 14: Summary of findings and certainty of evidence
methods handbook · 2024
Selected page text; cited sections · 14.1; 14.2.1–14.2.2 - Assessing risk of bias in a randomized trial
methods handbook · 2024
Selected handbook sections; not a full independent methods review · Sections 8.2–8.4: randomization, missing data and selective reporting
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Why do animal studies and impressive laboratory mechanisms not settle whether a supplement helps people?
Selected-source overview · Independent review pending. Read the evidence context.
A mechanism can explain how something might work without establishing that it improves people's health. Animal or laboratory conditions, participants and doses may differ from real human use. Human research must examine the actual intervention, relevant outcomes, comparison group and harms. Mechanistic evidence helps develop questions and interventions; it does not by itself settle clinical benefit or the best way to use a supplement.[7][8]
Evidence behind this answer
- Checklist for Understanding Health News Stories
agency explanation · Date not stated
Selected page passages inspected · Animal and laboratory studies versus human evidence; participant relevance; meaningful outcomes and limitations - Research Framework
agency evidence explanation · Date not stated
Selected page passages inspected · Mechanistic and translational research versus clinical efficacy; intervention optimization and human outcomes
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does a Phase 1 trial establish long-term benefit for every patient?
Selected-source overview · Independent review pending. Read the evidence context.
No. Early studies mainly address bounded human safety and dose-related questions. Wider benefit and longer-term risks require their own evidence.[9]
Evidence behind this answer
- Step 3: Clinical Research
agency research framework · Date not stated
Selected relevant official page passages inspected · Phases 1–4, protocol questions and changing safety/efficacy scope
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does Phase 4 mean a drug is still being studied before initial approval?
Selected-source overview · Independent review pending. Read the evidence context.
No. FDA describes Phase 4 studies as work after approval. Approval and continuing evidence collection are separate milestones.[9]
Evidence behind this answer
- Step 3: Clinical Research
agency research framework · Date not stated
Selected relevant official page passages inspected · Phases 1–4, protocol questions and changing safety/efficacy scope
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does a ClinicalTrials.gov number prove an intervention succeeded?
Selected-source overview · Independent review pending. Read the evidence context.
No. It identifies a study record. Registration is not a positive result, completed evidence appraisal or proof of efficacy.[10]
Evidence behind this answer
- Disclaimer
agency registry scope statement · Date not stated
Indexed official disclaimer and matching homepage statement inspected; direct disclaimer returned a minimal script-dependent page · Sponsor/investigator responsibility and limits of government review/approval
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does listing on ClinicalTrials.gov mean the government approved every study’s safety and science?
Selected-source overview · Independent review pending. Read the evidence context.
No. The platform explicitly says the government does not review or approve all listed studies; sponsors and investigators submit the information.[10]
Evidence behind this answer
- Disclaimer
agency registry scope statement · Date not stated
Indexed official disclaimer and matching homepage statement inspected; direct disclaimer returned a minimal script-dependent page · Sponsor/investigator responsibility and limits of government review/approval
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
What the sources explain
Cochrane assesses risk of bias, inconsistency, indirectness, imprecision, and publication bias. It evaluates the body of evidence for each outcome and requires reasons for certainty judgments.[2]
When findings differ, first compare who was studied, what exposure or treatment was tested, the comparator, outcome, and follow-up. Differences can make evidence indirect for the question a reader actually has.[2]
NCCIH encourages checking publication date and the larger evidence base. New work may support or contradict earlier findings. This atlas’s check date records source access, not an assertion that every newer paper was searched.[1]
A randomized trial still needs a bias assessment
Random assignment helps create comparable groups but is not the same as blinding. Concealed allocation, departures from assigned treatment, missing outcomes, measurement methods and selective reporting can affect a trial. An intention-to-treat analysis asks about assignment to a treatment strategy; analyzing only people who adhered can answer another question and lose some protection from randomization. Design labels alone do not settle credibility.[5]
What makes a review systematic?
A systematic review uses an explicit, reproducible search and selection process for a defined question. Searching one database or collecting convenient positive papers can miss eligible studies. Trial registries, multiple databases and other appropriate sources can help identify unpublished or differently reported findings. The search date and inclusion criteria show which evidence the review could have considered. A long reference list alone does not demonstrate these methods.[3]
Why a meta-analysis is not a vote count
Meta-analysis combines estimates with statistical weighting; it does not count which side has more papers. The combined result can mislead when studies differ importantly or share biases. Pooling is useful only alongside attention to the question, study methods and the reasons results differ. A precise combined estimate can still be systematically wrong.[6]
Drug-development phases have different main purposes
| Phase | Main question | Important boundary |
|---|---|---|
| Phase 1 | Early human safety, handling and dose-related questions. | Not proof of lasting benefit in all patients.[9] |
| Phase 2 | Further efficacy and side-effect questions in a selected population. | Earlier findings still need appropriate confirmation.[9] |
| Phase 3 | Treatment benefit and safety in larger studies. | The actual comparator and outcomes still matter.[9] |
| Phase 4 | Studies after approval. | Approval does not end research or safety assessment.[9] |
Questions still to cover
Further work: full systematic searches for individual health claims; outcome-specific risk-of-bias and certainty appraisal; independent subject-matter review.
References
- How To Make Sense of a Scientific Journal Article
Agency explanation
NCCIH · Content/publication date: not stated
Accessed: 2026-10-06 UTC · Selected page text; cited sections
Cited sections: Abstract; Main sections; Study date - Chapter 14: Summary of findings and certainty of evidence
Methods handbook
Cochrane; Schünemann and colleagues · Content/publication date: 2024
Accessed: 2026-10-06 UTC · Selected page text; cited sections
Cited sections: 14.1; 14.2.1–14.2.2 - Searching for and selecting studies
Methods handbook
Cochrane · Content/publication date: 2025
Accessed: 2026-10-06 UTC · Selected handbook sections; not a full independent methods review
Cited sections: Sections 4.2–4.4: search coverage and multiple reports - Collecting data
Methods handbook
Cochrane · Content/publication date: 2024
Accessed: 2026-10-06 UTC · Selected handbook sections; not a full independent methods review
Cited sections: Sections 5.2–5.4: study characteristics, outcomes and data sources - Assessing risk of bias in a randomized trial
Methods handbook
Cochrane · Content/publication date: 2024
Accessed: 2026-10-06 UTC · Selected handbook sections; not a full independent methods review
Cited sections: Sections 8.2–8.4: randomization, missing data and selective reporting - Analysing data and undertaking meta-analyses
Methods handbook
Cochrane · Content/publication date: 2024
Accessed: 2026-10-06 UTC · Selected handbook sections; not a full independent methods review
Cited sections: Sections 10.1–10.2: purpose and limits of pooling - Checklist for Understanding Health News Stories
Agency explanation
NCCIH / NIH · Content/publication date: not stated
Accessed: 2026-10-06 UTC · Selected page passages inspected
Cited sections: Animal and laboratory studies versus human evidence; participant relevance; meaningful outcomes and limitations - Research Framework
Agency evidence explanation
NCCIH / NIH · Content/publication date: not stated
Accessed: 2026-10-06 UTC · Selected page passages inspected
Cited sections: Mechanistic and translational research versus clinical efficacy; intervention optimization and human outcomesSite footer last-updated date is not treated as the document's content date.
- Step 3: Clinical Research
Agency research framework
US FDA · Content/publication date: not stated
Accessed: 2026-10-07 UTC · Selected relevant official page passages inspected
Cited sections: Phases 1–4, protocol questions and changing safety/efficacy scope - Disclaimer
Agency registry scope statement
ClinicalTrials.gov / US National Library of Medicine · Content/publication date: not stated
Accessed: 2026-10-07 UTC · Indexed official disclaimer and matching homepage statement inspected; direct disclaimer returned a minimal script-dependent page
Cited sections: Sponsor/investigator responsibility and limits of government review/approvalRegistry responsibility statement, not a study result or a declaration that no listed study has regulatory oversight.
Scope & review
- Population
- Readers of health research
- Exposure or intervention
- Evidence interpretation
- Comparison
- No independent intervention comparison
- Outcomes
- Scope and certainty concepts
- Timeframe
- Source snapshot; no new follow-up analysis
- Jurisdiction
- Methodological framework
Selected-source educational explainer. Cited page sections or indexed abstracts were inspected as specified for each source. This is not a systematic search, a formal evidence grade, or an independent clinical expert review; topic and applicability judgments are editorial. The edition 3.8 check applies to selected additions and named reused passages; older references retain their individual access dates.
Sources checked on their individual access dates. Selected sources were checked; ongoing surveillance and qualified review have separate statuses on the coverage page.
Revision history
- 2026-10-06 UTC: Domain-entry primer added; cited sections checked and remaining questions listed.
- 2026-10-06 UTC: Expanded definitions, categories, evidence boundaries and locally sourced questions; selected sources checked with access limits recorded. Independent expert review remains incomplete.
- 2026-10-07 UTC: Edition 3.8: added definitions, worked distinctions and sourced questions about evidence, testing, medicines and exposure. Qualified review remains pending.
What this article still leaves open
- full systematic searches for individual health claims
- outcome-specific risk-of-bias and certainty appraisal
- independent subject-matter review
- Protocol/result matching, prespecified outcomes, full methods, disclosure and harms appraisal for each referenced study.
Suggest a correction
Submit a content correction to the editorial queue, or download a local note. Leave out personal medical details. Submitted text is stored privately with a browser receipt session and is visible to this browser and the editor. Clearing cookies removes access to your submission history. This is not an account or a medical service.
Your submitted corrections for this article
Explore the topic map
Browse the health domains connected to this article. The map also identifies topics whose articles remain unwritten.